Lapatinib Resistance in Patients With Breast Cancer
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- Case Comprehensive Cancer Center
- Study ID
- NCT00898573
- Status
- Withdrawn
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- lapatinib ditosylate — DRUG
- fluorescence in situ hybridization — GENETIC
- gene expression analysis — GENETIC
- mutation analysis — GENETIC
- polymerase chain reaction — GENETIC
- reverse transcriptase-polymerase chain reaction — GENETIC
- cell sorting — OTHER
- immunohistochemistry staining method — OTHER
- laboratory biomarker analysis — OTHER
Study Details
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about cancer and the development of drug resistance in patients. PURPOSE: This research study is looking at lapatinib resistance in patients with breast cancer.
Key Dates
- Start date
- Jul 31, 2008
- Status verified
- Oct 2015
Study Design
- Enrollment
- 0 participants (actual)
Primary Outcome Measure
Secondary ErbB2 mutations
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center | Cleveland | Ohio | 44195 | - |
| Geauga Regional Hospital | Cleveland | Ohio | 44024 | - |
| Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center | Cleveland | Ohio | 44106-5065 | - |
| Lake/University Ireland Cancer Center | Cleveland | Ohio | 44060 | - |
| Mercy Cancer Center at Mercy Medical Center | Cleveland | Ohio | 44708 | - |
| Southwest General Health Center | Cleveland | Ohio | 44130 | - |
| UHHS Chagrin Highlands Medical Center | Cleveland | Ohio | 44122 | - |
| UHHS Westlake Medical Center | Cleveland | Ohio | 44145 | - |
| University Suburban Health Center | Cleveland | Ohio | 44121 | - |
Find similar trials in Cleveland, OH
By condition
By specialty
By research site
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center· Cleveland, OHGeauga Regional Hospital· Cleveland, OHIreland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center· Cleveland, OHLake/University Ireland Cancer Center· Cleveland, OHMercy Cancer Center at Mercy Medical Center· Cleveland, OHSouthwest General Health Center· Cleveland, OH
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama